Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Контроль гликемии у больных сахарным диабетом и кардиальной патологией
Контроль гликемии у больных сахарным диабетом и кардиальной патологией
Кочергина И.И. Контроль гликемии у больных сахарным диабетом и кардиальной патологией. Consilium Medicum. 2017; 19 (1): 56–60.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В статье представлены данные о распространенности сахарного диабета, роли гипер- и гипогликемии в развитии кардиоваскулярных осложнений, важности самоконтроля для своевременного выявления острых осложнений и компенсации сахарного диабета.
Ключевые слова: сахарный диабет, кардиоваскулярные осложнения, самоконтроль, глюкометр Контур Плюс.
Ключевые слова: сахарный диабет, кардиоваскулярные осложнения, самоконтроль, глюкометр Контур Плюс.
________________________________________________
The article presents data on the prevalence of diabetes, the role of hyper- and hypoglycemia in the development of cardiovascular complications, the importance of self-monitoring for early detection of acute complications of diabetes and compensation.
Key words: diabetes mellitus, cardiovascular complications, self-control, glukometr Contour Plus.
Key words: diabetes mellitus, cardiovascular complications, self-control, glukometr Contour Plus.
Полный текст
Список литературы
1. IDF Diabetes Atlas. 6-th edition. 20166. Available from: http://www.idf.org/diabetesatlas
2. www.who.int
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Структура сердечно-сосудистой заболеваемости и смертности в РФ за 2004 г. Клиническая медицина. 2005; 1: 3–8. / Struktura serdechno-sosudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klinicheskaia meditsina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S, Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3: 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Ощепкова Е.В. Смертность населения от сердечно-сосудистых заболеваний в Российской Федерации и пути по ее снижению. Кардиология. 2009; 2: 267–72. / Oshchepkova E.V. Smertnost' naseleniia ot serdechno-sosudistykh zabolevanii v Rossiiskoi Federatsii i puti po ee snizheniiu. Kardiologiia. 2009; 2: 267–72. [in Russian]
11. Бетуганова Л.В., Эльгаров А.А., Байсултанова М.Г. и др. Инфаркт миокарда: частота, половозрастные, профессиональные и клинические особенности. Кардиосоматика. 2014; 2: 10–14. / Betuganova L.V., Elgarov A.A., Baysultanova M.B. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. Cardiosomatics. 2014; 2: 10–14. [in Russian]
12. Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. Учебное пособие. 2-е изд., перераб. и доп. М.: ГЕОТАР-Медиа, 2014; c. 1032. / Ametov A.S. Sakharnyi diabet 2 tipa. Problemy i resheniia. Uchebnoe posobie. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2014; c. 1032. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
15. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
16. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
17. Дедов И.И., Шестакова М.В., Галстян Г.Р. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. 8-й выпуск. Сахарный диабет. 2017; 20 (1S): 1–112. / Dedov I.I., Shestakova M.V., Galstian G.R. i dr. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 7-i vypusk. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
18. Анциферов М.Б., Котешкова О.М. Управление сахарным диабетом: организация и значение самоконтроля. Трудный пациент. 2009; 7 (10). / Antsiferov M.B., Koteshkova O.M. Upravlenie sakharnym diabetom: organizatsiia i znachenie samokontrolia. Trudnyi patsient. 2009; 7 (10). [in Russian]
19. Глюкометр Контур Плюс. http://diabetes.ascensia.com.ru/homepage/ / Gliukometr Kontur Plius. http://diabetes.ascensia.com.ru/homepage/ [in Russian]
20. Baum et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. DiabTech Ther. 2006; 8(3): 347-57.
2. www.who.int
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Struktura serdechno-sosudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klinicheskaia meditsina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S, Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3: 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Oshchepkova E.V. Smertnost' naseleniia ot serdechno-sosudistykh zabolevanii v Rossiiskoi Federatsii i puti po ee snizheniiu. Kardiologiia. 2009; 2: 267–72. [in Russian]
11. Betuganova L.V., Elgarov A.A., Baysultanova M.B. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. Cardiosomatics. 2014; 2: 10–14. [in Russian]
12. Ametov A.S. Sakharnyi diabet 2 tipa. Problemy i resheniia. Uchebnoe posobie. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2014; c. 1032. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
15. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
16. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
17. Dedov I.I., Shestakova M.V., Galstian G.R. i dr. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 7-i vypusk. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
18. Antsiferov M.B., Koteshkova O.M. Upravlenie sakharnym diabetom: organizatsiia i znachenie samokontrolia. Trudnyi patsient. 2009; 7 (10). [in Russian]
19. Gliukometr Kontur Plius. http://diabetes.ascensia.com.ru/homepage/ [in Russian]
20. Baum et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. DiabTech Ther. 2006; 8(3): 347-57.
2. www.who.int
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Структура сердечно-сосудистой заболеваемости и смертности в РФ за 2004 г. Клиническая медицина. 2005; 1: 3–8. / Struktura serdechno-sosudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klinicheskaia meditsina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S, Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3: 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Ощепкова Е.В. Смертность населения от сердечно-сосудистых заболеваний в Российской Федерации и пути по ее снижению. Кардиология. 2009; 2: 267–72. / Oshchepkova E.V. Smertnost' naseleniia ot serdechno-sosudistykh zabolevanii v Rossiiskoi Federatsii i puti po ee snizheniiu. Kardiologiia. 2009; 2: 267–72. [in Russian]
11. Бетуганова Л.В., Эльгаров А.А., Байсултанова М.Г. и др. Инфаркт миокарда: частота, половозрастные, профессиональные и клинические особенности. Кардиосоматика. 2014; 2: 10–14. / Betuganova L.V., Elgarov A.A., Baysultanova M.B. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. Cardiosomatics. 2014; 2: 10–14. [in Russian]
12. Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. Учебное пособие. 2-е изд., перераб. и доп. М.: ГЕОТАР-Медиа, 2014; c. 1032. / Ametov A.S. Sakharnyi diabet 2 tipa. Problemy i resheniia. Uchebnoe posobie. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2014; c. 1032. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
15. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
16. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
17. Дедов И.И., Шестакова М.В., Галстян Г.Р. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. 8-й выпуск. Сахарный диабет. 2017; 20 (1S): 1–112. / Dedov I.I., Shestakova M.V., Galstian G.R. i dr. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 7-i vypusk. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
18. Анциферов М.Б., Котешкова О.М. Управление сахарным диабетом: организация и значение самоконтроля. Трудный пациент. 2009; 7 (10). / Antsiferov M.B., Koteshkova O.M. Upravlenie sakharnym diabetom: organizatsiia i znachenie samokontrolia. Trudnyi patsient. 2009; 7 (10). [in Russian]
19. Глюкометр Контур Плюс. http://diabetes.ascensia.com.ru/homepage/ / Gliukometr Kontur Plius. http://diabetes.ascensia.com.ru/homepage/ [in Russian]
20. Baum et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. DiabTech Ther. 2006; 8(3): 347-57.
________________________________________________
2. www.who.int
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Struktura serdechno-sosudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klinicheskaia meditsina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S, Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3: 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Oshchepkova E.V. Smertnost' naseleniia ot serdechno-sosudistykh zabolevanii v Rossiiskoi Federatsii i puti po ee snizheniiu. Kardiologiia. 2009; 2: 267–72. [in Russian]
11. Betuganova L.V., Elgarov A.A., Baysultanova M.B. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. Cardiosomatics. 2014; 2: 10–14. [in Russian]
12. Ametov A.S. Sakharnyi diabet 2 tipa. Problemy i resheniia. Uchebnoe posobie. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2014; c. 1032. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
15. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
16. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
17. Dedov I.I., Shestakova M.V., Galstian G.R. i dr. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 7-i vypusk. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
18. Antsiferov M.B., Koteshkova O.M. Upravlenie sakharnym diabetom: organizatsiia i znachenie samokontrolia. Trudnyi patsient. 2009; 7 (10). [in Russian]
19. Gliukometr Kontur Plius. http://diabetes.ascensia.com.ru/homepage/ [in Russian]
20. Baum et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. DiabTech Ther. 2006; 8(3): 347-57.
Авторы
И.И.Кочергина
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1
kii7@yandex.ru
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1
kii7@yandex.ru
________________________________________________
I.I.Kochergina
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
kii7@yandex.ru
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
kii7@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.